Nicholas Scanlon MD (He/Him)

Asthma & Allergic Conditions, Pediatric Asthma & Allergic Conditions, Clinical & Laboratory Immunology

Assistant Clinical Professor

8899 University Center LnSuite 230San Diego, CA 92122
Fax+1 404-616-9204

Dr. Scanlon is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Scanlon's full profile Already have an account?

Summary

Dr. Nicholas Scanlon is an Allergy & Immunology specialist based in San Diego, CA, with a focus on asthma and allergic conditions, including pediatric cases and clinical immunology. He earned his medical degree from the University of Alabama School of Medicine and completed his residency and chief residency in Internal Medicine at Emory University before pursuing a fellowship in Allergy and Immunology at the University of California (San Diego) Medical Center. He currently serves as an Assistant Clinical Professor at the UC San Diego Allergy, Immunology, and Angioedema Center. Dr. Scanlon has expertise in managing allergic contact dermatitis, asthma, chronic sinusitis, HIV/AIDS, and food allergies. His research work includes publications on topics such as vaccine efficacy and immune responses in transplant recipients. Notably, he has been involved in several Adaptive COVID-19 Treatment Trials. Over his career, Dr. Scanlon has received several honors, including awards from the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology.

Education & Training

University of California (San Diego) Medical CenterFellowship, Allergy and Immunology, 2021 - 2023
Emory University School of MedicineChief Residency, Internal Medicine, 2020 - 2021
Emory University School of MedicineResidency, Internal Medicine, 2017 - 2020
University of Alabama School of MedicineClass of 2017
Harding UniversityBS, Biochemistry & Molecular Biology, Summa Cum Laude, 2008 - 2012

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2021 - 2027
GA State Medical License 2017 - 2021
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Chrysalis Project Award American Academy of Allergy, Asthma, and Immunology, 2019
NIH StARR Grant Emory University School of Medicine, 2019
SPARK Award American College of Allergy, Asthma, and Immunology, 2018

Clinical Trials

Adaptive COVID-19 Treatment Trial (ACTT) Start of enrollment: 2020 Feb 21
COMPLETED
PHASE3
Adaptive COVID-19 Treatment Trial 2 (ACTT-2) Start of enrollment: 2020 May 08
COMPLETED
PHASE3
Adaptive COVID-19 Treatment Trial 3 (ACTT-3) Start of enrollment: 2020 Aug 05
COMPLETED
PHASE3

Publications & Presentations

PubMed

2 citations
Refractory Status Epilepticus Associated With a Pathogenic Variant in TNFRSF13B.
Jennifer H Yang, Nicholas Scanlon, Wonhee Woo, Jamie N LaBuzetta, Cynthia Gonzalez
Cureus. 2023-11-01
2 citations
Anaphylaxis From Ethylene Oxide-Sterilized Dialysis Tubing and Needles: A Case Report.
Clarkson Crane, Robyn A Cunard, Natalie Sweiss, Nicholas Scanlon, Taylor A Doherty
American Journal of Kidney Diseases. 2023-08-01
428 citations
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
Hana M. El Sahly, Lindsey R. Baden, Brandon Essink, Susanne Doblecki-Lewis, Judith M. Martin
The New England Journal of Medicine. 2021-09-22

Journal Articles

The Role of Systems Vaccinology in Understanding the Immune Defects to Vaccination in Solid Organ Transplant Recipients
Scanlon, N, Saklawi, Y, Rouphael, N., Frontiers in Immunology, 11/25/2020
Direct oral amoxicillin challenge without preliminary skin testing in adult patients with allergy and at low risk with reported penicillin allergy
Kuruvilla, M, Shih, J, Patel, K, and Scanlon, N., Allergy and Asthma Proceedings, 1/1/2019
Brief Report: Enhanced Allogeneic Cellular Responses to Mismatched HLA-B Antigens Results in More Efficient Killing of HIV Infected Cells
Sabbaj, S, Scanlon, N, Du, VY, Wang, Y, Tang, J, Hunter, E, and Goepfert, PA, JAIDS, 4/15/2016

Press Mentions

Low- or No-Risk Penicillin Allergy Can Be Confirmed with Oral Challenge TestFebruary 25th, 2019

Committees

Medical Student Representative, Advisory Committee on LGBTQ Issues - American Medical Association 2015 - Present
Chair, Minority Issues Committee - American Medical Association Medical Student Section 2013 - 2015

Professional Memberships

American Medical Association - AMA
Member
American College of Physicians - ACP
Member
American Academy of Allergy Asthma and Immunology - AAAAI
Member
American College of Allergy, Asthma, and Immunology - ACAAI
Member

Other Languages

Spanish

External Links

ACAAI 2018: Oral Amoxicillin Challenge Safe in Low-Risk Patients With Penicillin Allergy Labelhttps://www.practiceupdate.com/content/acaai-2018-oral-amoxicillin-challenge-safe-in-low-risk-patients-with-penicillin-allergy-label/76265